SEQUANA MEDICAL

Environment:

Sequana Medical strives to minimize its ecological footprint across every facet of its business, including responsible sourcing of components and raw materials, replacing air travel by video conferencing whenever feasible and implementing a hybrid workplace to reduce carbon emissions as much as possible. The company's headquarter is also equipped with solar panels.

Social: 

Sequana Medical is a pioneer in developing innovative treatments for fluid overload, a serious and frequent clinical complication in conditions such as liver failure, heart failure, and cancer. When traditional treatments like diuretics are no longer effective, patients are left with limited treatment options. The company's breakthrough device designation for the alfapump in treating ascites due to liver cirrhosis underscores the urgency and unmet medical need within this domain. Sequana Medical's transformative treatments not only improves the quality of life for patients but also restores a sense of normalcy, giving them the invaluable gift of reclaiming their lives. In prioritizing treatments for those often overlooked, Sequana Medical embodies a socially conscious commitment to making a meaningful impact on the well-being of those individuals and communities.

Sequana Medical actively enhances its social impact by partnering with patient advocacy groups, recognizing their vital role in championing the needs of individuals suffering from fluid overload. These collaborations provide crucial insights for the development of the company's innovative treatment solutions and contribute to raising awareness about the underlying conditions. In working closely with these advocacy groups, Sequana Medical not only advances medical solutions but also actively supports and amplifies the voices of those facing fluid overload challenges.

Governance:

Sequana Medical is equally committed to governance impact, fostering a corporate culture built on transparency, accountability, and ethical practices and strives to create a corporate environment that prioritizes ethical decision-making and integrity at every level. 

As the company prepares for commercial launch of its alfapump in the United States, it is diligently enhancing its internal systems to align with the various federal and state fraud and abuse laws, as well as the patient privacy and security regulations, including the federal Anti-Kickback Statute, federal false claims laws, the federal Health Insurance Portability and Accountability Act of 1996 and the Physician Payments Sunshine Act. Sequana Medical is also subject to European and other foreign law equivalents of each of the laws, including reporting requirements detailing interactions with and payments to healthcare providers.

Sequana Medical's alfapump collects and stores confidential and sensitive information. This information includes, among other things, data from patients using the alfapump. Sequana Medical implements effective security measures to ensure that this information remains secure.

Sequana Medical is also committed to comply with the EU General Data Protection Regulation (the GDPR) and has appointed a Data Protection Officer within the company.